Providing a diverse range of perspectives from bullish to bearish, 18 analysts have published ratings on Travelers Companies TRV in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 2 | 12 | 1 | 1 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 1 | 0 | 0 |
3M Ago | 2 | 2 | 10 | 1 | 1 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $230.39, a high estimate of $253.00, and a low estimate of $212.00. This current average has increased by 2.28% from the previous average price target of $225.25.
Breaking Down Analyst Ratings: A Detailed Examination
A clear picture of Travelers Companies's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Scott Heleniak | RBC Capital | Maintains | Sector Perform | $225.00 | $225.00 |
Michael Phillips | Morgan Stanley | Raises | Equal-Weight | $216.00 | $214.00 |
Frank Lee | TD Cowen | Lowers | Buy | $252.00 | $261.00 |
Brian Meredith | UBS | Lowers | Neutral | $230.00 | $237.00 |
Meyer Shields | Keefe, Bruyette & Woods | Lowers | Market Perform | $231.00 | $241.00 |
Yaron Kinar | Jefferies | Lowers | Hold | $219.00 | $222.00 |
Mark Dwelle | RBC Capital | Lowers | Sector Perform | $225.00 | $230.00 |
David Motemaden | Evercore ISI Group | Lowers | Outperform | $250.00 | $253.00 |
Harry Fong | Roth MKM | Maintains | Buy | $240.00 | - |
Meyer Shields | Keefe, Bruyette & Woods | Lowers | Market Perform | $231.00 | $241.00 |
Michael Ward | Citigroup | Raises | Neutral | $226.00 | $215.00 |
Michael Phillips | Morgan Stanley | Raises | Equal-Weight | $230.00 | $222.00 |
Alex Scott | Goldman Sachs | Raises | Sell | $212.00 | $186.00 |
David Motemaden | Evercore ISI Group | Raises | Outperform | $253.00 | $230.00 |
Meyer Shields | Keefe, Bruyette & Woods | Raises | Market Perform | $241.00 | $215.00 |
Jimmy Bhullar | JP Morgan | Raises | Underweight | $213.00 | $194.00 |
Vikram Gandhi | HSBC | Raises | Hold | $240.00 | $218.00 |
Paul Newsome | Piper Sandler | Maintains | Neutral | $213.00 | - |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Travelers Companies. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Travelers Companies compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Travelers Companies's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
For valuable insights into Travelers Companies's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Travelers Companies analyst ratings.
All You Need to Know About Travelers Companies
Travelers offers a broad product range and participates in both commercial and personal insurance lines. Its commercial operations offer a variety of coverage types for companies of any size but concentrate on serving midsize businesses. Its personal lines are roughly evenly split between auto and homeowners insurance. Travelers derives 6% of its premiums from foreign markets.
Key Indicators: Travelers Companies's Financial Health
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Travelers Companies's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 15.7%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Travelers Companies's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 9.93%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Travelers Companies's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 4.47%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Travelers Companies's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.88%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Travelers Companies's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.32, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
The Core of Analyst Ratings: What Every Investor Should Know
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.